Cargando…
Accepting Immunotherapy After Multiline Treatment Failure: An Exploration of the Anxiety and Depression in Patients with Advanced Cancer Experience
BACKGROUND: Tumor immunotherapy is a promising therapeutic strategy for patients with advanced cancers, and some tumors have profound and durable tumor regression. However, immunotherapy is still in the clinical trial stage with elusive long-term effects and complications as a new strategy. It is un...
Autores principales: | Xie, Qingqing, Sun, Caixia, Fei, Zhenghua, Yang, Xujing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743985/ https://www.ncbi.nlm.nih.gov/pubmed/35023904 http://dx.doi.org/10.2147/PPA.S346171 |
Ejemplares similares
-
Dark Flow, Depression and Multiline Slot Machine Play
por: Dixon, Mike J., et al.
Publicado: (2017) -
Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
por: Liu, Yanfeng, et al.
Publicado: (2022) -
Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
The Role and Clinical Effectiveness of Multiline Chemotherapy in Advanced Desmoplastic Small Round Cell Tumor
por: Jeong, Hyehyun, et al.
Publicado: (2021) -
Multiline treatment of advanced squamous cell carcinoma of the lung: A case report and review of the literature
por: Yang, Xin, et al.
Publicado: (2019)